{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:31:42Z","timestamp":1759206702373,"version":"3.41.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Am J Phys Med Rehabil"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Investigation of the frequency and progression of ventilatory muscle dysfunction in patients with inclusion body myositis, the most common myopathy after age of 50 yrs. Prior research is limited to case series and cross-section studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design<\/jats:title>\n            <jats:p>This is a retrospective review of pulmonary function tests, respiratory symptoms, and muscle strength testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 54 patients reviewed (mean age: 65 \u00b1 9 yrs and disease duration: 7 \u00b1 7 yrs), the majority (<jats:italic toggle=\"yes\">n<\/jats:italic> = 32, 59%) had restrictive forced vital capacity deficits at initial visit. Patients with reduced forced vital capacity showed higher prevalence of respiratory symptoms; but age, body mass index, and limb strength were similar when compared with patients without restrictive forced vital capacity. Mean rate of forced vital capacity decline of 0.108 l\/yr in inclusion body myositis patients. Lower baseline limb strength correlated with longer disease duration and future forced vital capacity decline (eg, weaker patients experienced faster decline).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Based on forced vital capacity, there is a high frequency of ventilatory pump muscle weakness in inclusion body myositis, which is associated with a higher burden of respiratory symptoms. Baseline strength may indicate risk of respiratory decline and need for vigilant screening. Importantly, ventilatory and limb muscle decline may not progress in a corresponding manner, highlighting the importance of pulmonary function surveillance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/phm.0000000000002114","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T21:00:19Z","timestamp":1665694819000},"page":"427-432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Characterizing Ventilatory Muscle Dysfunction in Inclusion Body Myositis"],"prefix":"10.1097","volume":"102","author":[{"given":"Gabrielle","family":"Brokamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh","family":"Hartog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Vilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerold","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakri H.","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. David","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"bib2-20250616","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jocn.2008.01.011","article-title":"Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis","volume":"15","year":"2008","journal-title":"J Clin Neurosci"},{"key":"bib3-20250616","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ncl.2014.04.001","article-title":"Inclusion body myositis","volume":"32","year":"2014","journal-title":"Neurol Clin"},{"key":"bib4-20250616","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","year":"2014","journal-title":"Neurology"},{"key":"bib5-20250616","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/nan.12149","article-title":"Mitochondrial and inflammatory changes in sporadic inclusion body myositis","volume":"41","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"bib6-20250616","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken","volume":"129","year":"2015","journal-title":"Acta Neuropathol"},{"key":"bib7-20250616","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/ene.15231","article-title":"Sirolimus leads to rapid and sustained clinical improvement of motor deficits in a patient with inclusion body myositis","volume":"29","year":"2022","journal-title":"Eur J Neurol"},{"key":"bib8-20250616","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PHM.0b013e31826edcf1","article-title":"Changing trends in the management of end-stage neuromuscular respiratory muscle failure: recommendations of an international consensus","volume":"92","year":"2013","journal-title":"Am J Phys Med Rehabil"},{"key":"bib9-20250616","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5535\/arm.2017.41.4.519","article-title":"Noninvasive respiratory management of patients with neuromuscular disease","volume":"41","year":"2017","journal-title":"Ann Rehabil Med"},{"key":"bib10-20250616","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pulmoe.2021.06.007","article-title":"Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration","volume":"27","year":"2021","journal-title":"Pulmonology"},{"key":"bib11-20250616","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1212\/01.WNL.0000145834.17020.86","article-title":"Primary respiratory failure in inclusion body myositis","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"bib12-20250616","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.104.3.975","article-title":"Inclusion body myositis as a cause of respiratory failure","volume":"104","year":"1993","journal-title":"Chest"},{"key":"bib13-20250616","first-page":"155","article-title":"Primary respiratory failure due to inclusion body myositis: think outside the box","volume":"77","year":"2013","journal-title":"Conn Med"},{"key":"bib14-20250616","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.nmd.2014.08.003","article-title":"Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis","volume":"24","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"bib15-20250616","doi-asserted-by":"crossref","first-page":"20584601221075796","DOI":"10.1177\/20584601221075796","article-title":"Subclinical involvement of the trunk muscles in idiopathic inflammatory myopathies","volume":"11","year":"2022","journal-title":"Acta Radiol Open"},{"key":"bib16-20250616","first-page":"725","article-title":"Changes in the normal maximal expiratory flow-volume curve with growth and aging","volume":"127","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"bib18-20250616","doi-asserted-by":"crossref","first-page":"e028150","DOI":"10.1136\/bmjopen-2018-028150","article-title":"Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies","volume":"9","year":"2019","journal-title":"BMJ Open"},{"key":"bib19-20250616","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ppul.23622","article-title":"Comparison of sitting and supine forced vital capacity in collagen VI-related dystrophy and laminin \u03b12-related dystrophy","volume":"52","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"bib20-20250616","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2014-310008","article-title":"Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement","volume":"87","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T21:03:28Z","timestamp":1750107808000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000002114","relation":{},"ISSN":["1537-7385","0894-9115"],"issn-type":[{"type":"electronic","value":"1537-7385"},{"type":"print","value":"0894-9115"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}